암 치료 반응 예측 방법
문의하기
| 기술분야 | 보건/의료 |
|---|---|
| 개발상태 | Lab tested |
| 보유기관 | |
| 기술유형 | |
| 지식재산권 | IPR applied but not yet granted |
| 보유국가 | 스페인 |
- 제품소개
- Summary바이오마커(GARP: 골지 관련 역행성 단백질 복합체) 및 암 치료, 바람직하게는 사르코마(악성종양)의 치료에 대한 반응을 예측하는 방법입니다. GARP의 발현은 TGFβ(Transforming growth factor beta; 세포 성장을 방해하는 인자)의 발현보다 더 제한적이기 때문에 치료 대상으로 사용하면TGFβ의 항암 효과를 보다 안전하고 효율적으로 차단 가능합니다.DescriptionThe Foundation for Biosanitary Research and Innovation of the Principality of Asturias (FINBA) (Spain) has applied for the patent of an invention related to a biomarker (GARP, Golgi Associated Retrograde Protein Complex) and a method for predicting or forecasting response to cancer treatment, preferably to the treatment of sarcomas. They are looking for a biomedical/biotechnological company interested in a license and/or collaboration agreement to develop and exploit this asset.Technology Keywords06002007 - In vitro Testing, Trials06003002 - Gene Expression, Proteome Research06001005 - Diagnostics, Diagnosis06001012 - Medical Research06002002 - Cellular and Molecular BiologyMarket Application Keywords05001005 - Molecular diagnosis05001002 - In-vitro diagnosticsSector GroupHealthType and Role of Partner SoughtBiomedical/Biotechnological company interested in a license and/or a collaboration agreement to develop and exploit this asset.Type of Partnership ConsideredCommercial agreement with technical assistanceResearch and development cooperation agreement